Ana Mitrović

1.1k total citations
42 papers, 837 citations indexed

About

Ana Mitrović is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ana Mitrović has authored 42 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Ana Mitrović's work include Peptidase Inhibition and Analysis (14 papers), Protease and Inhibitor Mechanisms (14 papers) and Endometriosis Research and Treatment (4 papers). Ana Mitrović is often cited by papers focused on Peptidase Inhibition and Analysis (14 papers), Protease and Inhibitor Mechanisms (14 papers) and Endometriosis Research and Treatment (4 papers). Ana Mitrović collaborates with scholars based in Slovenia, Serbia and Czechia. Ana Mitrović's co-authors include Janko Kos, Bojana Mirković, Stanislav Gobec, Urša Pečar Fonović, Izidor Sosič, Barbara Breznik, Svetlana Dragojević-Dikić, Milica Perišić Nanut, Anja Pišlar and Tamara T. Lah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Ana Mitrović

38 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Mitrović Slovenia 15 340 216 186 150 87 42 837
Chunlai Nie China 22 796 2.3× 293 1.4× 169 0.9× 90 0.6× 60 0.7× 57 1.3k
Pavel Spirin Russia 18 644 1.9× 109 0.5× 142 0.8× 43 0.3× 55 0.6× 90 1.0k
Ioannis Papasotiriou Greece 16 325 1.0× 234 1.1× 176 0.9× 40 0.3× 49 0.6× 72 747
Barbara Saxty United Kingdom 16 689 2.0× 201 0.9× 134 0.7× 81 0.5× 146 1.7× 33 1.1k
Jingyu Wu China 13 481 1.4× 77 0.4× 83 0.4× 46 0.3× 59 0.7× 43 825
Ana B. Herrero Spain 21 729 2.1× 229 1.1× 142 0.8× 57 0.4× 98 1.1× 42 1.1k
George W. Yip Singapore 16 297 0.9× 68 0.3× 127 0.7× 109 0.7× 126 1.4× 33 875
Susan Fong United States 15 675 2.0× 173 0.8× 227 1.2× 115 0.8× 23 0.3× 19 1.2k
Lin-Yu Lu United States 11 829 2.4× 370 1.7× 105 0.6× 19 0.1× 98 1.1× 11 1.1k
Praveenkumar Shetty India 18 496 1.5× 122 0.6× 181 1.0× 20 0.1× 44 0.5× 58 847

Countries citing papers authored by Ana Mitrović

Since Specialization
Citations

This map shows the geographic impact of Ana Mitrović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Mitrović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Mitrović more than expected).

Fields of papers citing papers by Ana Mitrović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Mitrović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Mitrović. The network helps show where Ana Mitrović may publish in the future.

Co-authorship network of co-authors of Ana Mitrović

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Mitrović. A scholar is included among the top collaborators of Ana Mitrović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Mitrović. Ana Mitrović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Švajger, Urban, Ana Mitrović, Borut Prestor, et al.. (2025). Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models. Frontiers in Immunology. 16. 1708281–1708281.
2.
Mitrović, Ana, Damijan Knez, Martina Hrast, et al.. (2025). Biochemical characteristics of the 6-nitro regioisomer of nitroxoline and its 1,2,3,4-tetrahydroquinoline analogues. Acta Pharmaceutica. 75(2). 235–257.
3.
Fonović, Urša Pečar, et al.. (2025). The α- to γ-enolase switch: The role and regulation of γ-enolase during oligodendrocyte differentiation. International Journal of Biological Macromolecules. 301. 140464–140464.
4.
Zubrienė, Asta, et al.. (2024). New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 67(15). 12984–13018. 9 indexed citations
5.
Fonović, Urša Pečar, Janko Kos, & Ana Mitrović. (2024). Compensational role between cathepsins. Biochimie. 226. 62–76. 9 indexed citations
6.
Mitrović, Ana, et al.. (2023). EPRI approach on studying deep skin penetration of tretinoin-containing liposomes. SHILAP Revista de lepidopterología. 10(3). 1343–1348. 1 indexed citations
7.
Mitrović, Ana, Izidor Sosič, Pamela Martínez-Orellana, et al.. (2023). Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection. Antiviral Research. 216. 105655–105655. 8 indexed citations
8.
Mitrović, Ana, et al.. (2022). New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity. Computational and Structural Biotechnology Journal. 20. 4667–4687. 7 indexed citations
9.
Pišlar, Anja, Ana Mitrović, Jerica Sabotič, et al.. (2020). The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors. PLoS Pathogens. 16(11). e1009013–e1009013. 78 indexed citations
10.
Mitrović, Ana, Jakob Kljun, Izidor Sosič, et al.. (2019). Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity. Inorganic Chemistry. 58(18). 12334–12347. 34 indexed citations
11.
Breznik, Barbara, Ana Mitrović, Tamara T. Lah, & Janko Kos. (2019). Cystatins in cancer progression: More than just cathepsin inhibitors. Biochimie. 166. 233–250. 66 indexed citations
12.
Ábrányi‐Balogh, Péter, László Petri, Tı́mea Imre, et al.. (2018). A road map for prioritizing warheads for cysteine targeting covalent inhibitors. European Journal of Medicinal Chemistry. 160. 94–107. 90 indexed citations
13.
Mitrović, Ana, Urša Pečar Fonović, & Janko Kos. (2017). Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells. European Journal of Cell Biology. 96(6). 622–631. 38 indexed citations
14.
Fonović, Urša Pečar, Ana Mitrović, Damijan Knez, et al.. (2017). Identification and characterization of the novel reversible and selective cathepsin X inhibitors. Scientific Reports. 7(1). 11459–11459. 13 indexed citations
15.
Dragojević-Dikić, Svetlana, et al.. (2015). Cervical poorly differentiated adenocarcinoma with dominant choriocarcinomatous pattern: A case report. Vojnosanitetski pregled. 72(7). 651–653. 1 indexed citations
16.
Mitrović, Ana, et al.. (2011). The effects of hyperbaric oxygen treatment on vigility of spermatozoids: Preliminary report. Acta Physiologica Hungarica. 98(1). 85–90. 3 indexed citations
17.
Dragojević-Dikić, Svetlana, et al.. (2010). An immunological insight into premature ovarian failure (POF). Autoimmunity Reviews. 9(11). 771–774. 78 indexed citations
18.
Mitrović, Ana, et al.. (2006). Hyperbaric oxygen and in vitro fertilisation. Australian and New Zealand Journal of Obstetrics and Gynaecology. 46(5). 456–457. 1 indexed citations
19.
Mitrović, Ana, et al.. (2006). Mean of CA 125 in making therapy decision in adnexal inflammatory tumors. Bosnian Journal of Basic Medical Sciences. 6(2). 3–6. 2 indexed citations
20.
Dragojević-Dikić, Svetlana, et al.. (2003). Correlative analyze of predictable factors of successful implantation in assisted reproduction programme. Srpski arhiv za celokupno lekarstvo. 131(7-8). 311–313. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunlai Nie Breakdown of academic impact, for papers by Pavel Spirin Breakdown of academic impact, for papers by Ioannis Papasotiriou Breakdown of academic impact, for papers by Barbara Saxty Breakdown of academic impact, for papers by Jingyu Wu Breakdown of academic impact, for papers by Ana B. Herrero Breakdown of academic impact, for papers by George W. Yip Breakdown of academic impact, for papers by Susan Fong Breakdown of academic impact, for papers by Lin-Yu Lu Breakdown of academic impact, for papers by Praveenkumar Shetty
Rankless by CCL
2026